中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性卒中诊治指南2023. 中华神经科杂志,2024,57(06)：523-559.

Majoie CB, et al. Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials. Lancet. 2023;402(10406):965-974.

Tanswell P, et al. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. Clin Pharmacokinet. 2002;41(15):1229-45.

Warach SJ, et al. Prospective Observational Cohort Study of Tenecteplase Versus Alteplase in Routine Clinical Practice. Stroke. 2022;53(12):3583-3593.

Powers WJ, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418.

Alamowitch S, et al. European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke. Eur Stroke J. 2023;8(1):8-54.

中国卒中学会,《中国卒中学会急性缺血性卒中再灌注治疗指南2024》编写组,王拥军. 中国卒中学会急性缺血性卒中再灌注治疗指南2024. 中国卒中杂志,2024,19(12):1460-1478.

Campbell BCV, et al. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. N Engl J Med. 2018;378(17):1573-1582.

Altersberger VL, et al. Bridging thrombolysis with tenecteplase versus endovascular thrombectomy alone for large-vessel anterior circulation stroke: a target trial emulation analysis. J Neurol Neurosurg Psychiatry. 2025:jnnp-2024-335325.

Meng X, et al. Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke: The ORIGINAL Randomized Clinical Trial. JAMA. 2024;332(17):1437-1445.

卓琳,等. 模拟目标试验概念及其关键要素. 中华儿科杂志,2024,62(08)：751-751.

Matthews AA, et al. Target trial emulation: applying principles of randomised trials to observational studies. BMJ. 2022;378:e071108.